David Moser, PhD, ABPP

Professor
Department
Psychiatry
Biography

Introduction

My primary research interest involves finding better ways to identify those individuals at greatest risk for vascular cognitive decline and, ultimately, finding ways to prevent or at least attenuate this process. A secondary line of research involves the assessment of decisional capacity for informed consent in various vulnerable populations, determining what factors (e.g. cognitive dysfunction, mental illness) are most likely to impair this capacity, and finding new ways to improve this capacity in those who are unable to make informed decisions on their own behalf.

Current Positions

  • Professor of Psychiatry
  • Vice Chair for Faculty Development

Education

  • BA in Psychology, Colby College, Waterville, ME
  • MS in Clinical Psychology, University of Florida, Gainesville, FL
  • PhD in Clinical Psychology, University of Florida, Gainesville, FL
  • Fellow in Neuropsychology, Brown University Medical School, Providence, RI

Graduate Program Affiliations

Licenses & Certifications

  • Clinical Neuropsychology, American Board of Professional Psychology
  • Health Service Provider, Iowa Bureau of Professional Licensing, Iowa
  • Psychology License, Iowa Board of Professional Licensing, Iowa

Research Concentration

My primary research interest involves vascular disease, how this contributes to cognitive decline in the elderly, and how to develop strategies for early identification of those individuals at greatest risk for such decline. Additional research interests include decision making and capacity for informed consent in vulnerable populations, and neuropsychological and emotional functioning in the following populations: post-stroke patients, schizophrenia and other mental illness, eating disorders.

 

Research areas
  • Vascular disease
  • Assessment of decisional capacity for informed consent in various vulnerable populations, determining what factors
  • Pathological gambling
  • Mood and cognitive changes
  • Cognitive dysfunction
  • Mental illness
  • Traumatic brain injury (TBI)
  • Neuropsychological and emotional functioning
  • Schizophrenia
  • Eating disorders
  • Huntington disease
  • Capacity for informed consent in psychiatric and general medical populations
  • Cardiovascular disease and cognition in the elderly